Although ROR and miR‐133 might be targeted for the development of novel antihypertrophic therapeutics based on the results of previous studies, the precise gene correlations of ROR and miR‐133 have not been elucidated.50 It has been verified that miR‐133 could prevent cardiac hypertrophy via inhibiting its targets RhoA and Cdc42. Here, LINC-ROR is linked to cardiac hypertrophy.